GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
Kapoor I, Sarvepalli SM, D'Alessio D, Grewal DS, Hadziahmetovic M.
Surv Ophthalmol. 2023 Nov-Dec;68(6):1071-1083. doi: 10.1016/j.survophthal.2023.07.002. Epub 2023 Jul 16.
Plasma Metabolomics Identifies Key Metabolites and Improves Prediction of Diabetic Retinopathy: Development and Validation across Multinational Cohorts.
Yang S, Liu R, Xin Z, Zhu Z, Chu J, Zhong P, Zhu Z, Shang X, Huang W, Zhang L, He M, Wang W.
Ophthalmology. 2024 Dec;131(12):1436-1446. doi: 10.1016/j.ophtha.2024.07.004. Epub 2024 Jul 5.
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L, Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH, Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A, Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR, Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM, Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P, Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J, Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG, Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M, Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O, Freitas G, Jardim A, Vasconcelos …
BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5.
Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study.
Yin L, Zhang D, Ren Q, Su X, Sun Z.
Medicine (Baltimore). 2020 Feb;99(9):e19236. doi: 10.1097/MD.0000000000019236.
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning.
Kim JA, Yoo HJ.
Diabetes Metab J. 2025 Jul;49(4):525-541. doi: 10.4093/dmj.2025.0242. Epub 2025 Jul 1.
Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X, Zhao S, Huang Y, Ma M, Li B, Li C, Zhu X, Xu X, Chen H, Zhang Y, Zhou C, Zheng Z.
J Am Heart Assoc. 2024 Jun 4;13(11):e032626. doi: 10.1161/JAHA.123.032626. Epub 2024 May 31.
Fenofibrate and diabetic retinopathy.
Karti O, Saatci AO.
Med Hypothesis Discov Innov Ophthalmol. 2024 Jul 1;13(1):35-43. doi: 10.51329/mehdiophthal1492. eCollection 2024.
Ocular Complications Associated With Diabetes And The Risk Of Sustainable Blindness; A Real World Analysis.
Mahmood T, Fahim MF, Ahsan S, Qidwai U, Memon MS.
J Pak Med Assoc. 2023 Jul;73(7):1453-1456. doi: 10.47391/JPMA.8001.
Diabetes-Associated Hyperglycemia Causes Rapid-Onset Ocular Surface Damage.
Weng J, Ross C, Baker J, Alfuraih S, Shamloo K, Sharma A.
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):11. doi: 10.1167/iovs.64.14.11.
Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes.
Floyd JL, Prasad R, Dupont MD, Adu-Rutledge Y, Anshumali S, Paul S, Li Calzi S, Qi X, Malepati A, Johnson E, Jumbo-Lucioni P, Crosson JN, Mason JO 3rd, Boulton ME, Welner RS, Grant MB.
Diabetologia. 2025 Apr;68(4):866-889. doi: 10.1007/s00125-024-06349-4. Epub 2025 Jan 28.
